Brief: PCI Biotech Q3 Operating Loss Widens To NOK 18.5 Million
Nov 27 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* REG-PCI BIOTECH: THIRD QUARTER 2019 RESULTS
* Q3 OPERATING LOSS NOK 18.5 MILLION VERSUS LOSS NOK 8.4
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE4lt4qh
Further company coverage: PCIB.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process